Background
==========

Exposure to aberrant or harmful environments during development and early life can be detrimental to later life health. From these observations is derived the Developmental Origins of Health and Disease (DOHaD) hypothesis \[[@dvx019-B1]\], which seeks to explain why the period from conception to birth and the first few years of life is critical for determining life-long susceptibility to non-communicable diseases (NCDs). Many NCD phenotypes are thought to be caused by developmental perturbations that are a consequence of altered epigenetic marks \[[@dvx019-B2], [@dvx019-B5]\], induced by environmental exposure during critical periods of development \[[@dvx019-B6]\]. Alteration to the epigenome regulates gene expression through DNA methylation, histone and chromatin modifications \[[@dvx019-B7], [@dvx019-B8]\] providing plasticity to the genome. Consequently, phenotypes under epigenetic regulation provide a pathway through which the genome can interact with the environment \[[@dvx019-B9]\]. If the epigenetic modifications occur at a time during which they are able to affect the germ line, such modifications may also influence development of the offspring \[[@dvx019-B6]\].

The interaction between the environment and the epigenome and the resulting phenotypic adaptations, coupled with the growing NCD epidemic, has led to the predictive adaptive response (PAR) hypothesis \[[@dvx019-B10]\]. This hypothesis states that nature of the PAR is determined by the degree of mismatch between the foetal pre-natal and its ultimate post-natal environments. This mismatch results from the information that the foetus receives on environmental conditions while *in utero*, to which it will respond adaptively by programming its biology to expect that environment. If the actual post-natal environment matches the prenatal prediction, then the PARs are appropriate and disease risk is low; if they do not match then the PAR is inappropriate, and disease risk is increased. For instance, obesity has a distinct epigenetic profile. This pattern could be established in early life as a response to the maternal, foetal and/or early post-natal environment, and later-life nutritional mismatch could mean that the individual has been programmed inappropriately, leading to an increased risk of obesity and associated diseases later in life \[[@dvx019-B11]\]. This implies that the epigenetic hallmarks of early-life exposures may be able to be maintained or 'stored' in such a way as to produce long-lasting effects \[[@dvx019-B12]\].

Along with stress, drugs and environmental toxicants, one of the main factors that can cause epigenetic perturbation is nutrition; evidence from humans, supported by experiments in rodents, suggest that early-life nutrition can affect the long-term health not only of the individual but also of their offspring \[[@dvx019-B13]\], potentially through epigenetic mechanisms \[[@dvx019-B16]\]. Consistent with the DOHaD hypothesis, strong links exist between both maternal and early-life nutrition and cardiovascular disease \[[@dvx019-B21]\], diabetes and obesity \[[@dvx019-B22]\] along with asthma and allergy, autoimmune disease, cancer and mental health \[[@dvx019-B23]\]. Inappropriate maternal nutrition in rodents has been linked to incorrect epigenetic 'priming' during foetal or post-natal life \[[@dvx019-B27], [@dvx019-B28]\]; in particular, experiments conducted in *Drosophila* show that diets high in carbohydrate content (sugar) have been shown to programme metabolic status and diabetes \[[@dvx019-B29], [@dvx019-B30]\].

Many nutrition-related phenotypes have been attributed to changes in epigenetic processes and a classic example of this is that of methyl supplementation, which influences coat colour in agouti mice \[[@dvx019-B31]\]. Nutrition influences are separated into direct effects (on the mother/father themselves) and also indirect (on the offspring or maternal provisioning) effects. Direct effects can be exemplified by high-fat diets inducing obesity and metabolic syndrome, due to the methylation pattern of particular genes and promoters involved in body weight and adipocyte differentiation such as leptin \[[@dvx019-B32]\] and peroxisome proliferator-activated receptor gamma (PPARγ) \[[@dvx019-B33]\] and the differential DNA methylation detected in metabolic syndrome in both humans and rodents \[[@dvx019-B34], [@dvx019-B35]\]. Indirect effects on offspring metabolic phenotype can occur via maternal diet. For example, rodents exposed to high-fat diets *in utero* have altered epigenetic patterns and methylation status of particular genes, for example those expressed in and secreted by adipose tissue such as adiponectin and leptin genes \[[@dvx019-B36]\]. Further, a high-fat diet during pregnancy and lactation can induce epigenetic modifications and differential expression of the μ-opioid receptor (involved in drug metabolism), and corresponding hypomethylation of the promoter regions of the gene, in mouse offspring \[[@dvx019-B37]\]. Additionally, maternal protein restriction in rodents can cause hypomethylation of particular genes involved in metabolic processes in foetus and offspring such as those that regulate metabolism in the liver \[[@dvx019-B38], [@dvx019-B39]\], those that contribute to cholesterol and fatty acid metabolism \[[@dvx019-B40]\] and those that regulate metabolic pathways that control lipid metabolism between the liver and adipose tissue \[[@dvx019-B41]\] and can also affect methylation in the developing placenta \[[@dvx019-B42]\]. Such epigenetic perturbation is not just limited to foetal and early life; the post-natal period is also susceptible to the epigenetic effects of nutrition. For example, hypermethylation of the promoter region of the anorexigenic neurohormone proopipmelanocortin occurs in overfed rats \[[@dvx019-B43]\], and post-natal folic acid supplementation can lead to hypermethylation of peroxisome proliferator-activated receptor alpha (PPARα), a nuclear transcription factor gene \[[@dvx019-B44]\]. This sensitivity of the epigenome to the effects of the environment (nutrition) also extends into adulthood, where epigenetic changes in response to nutritional changes have been observed in rats \[[@dvx019-B45]\].

In addition to metabolic genes, altered nutrition appears to have broader genomic consequences. For instance, a study in dairy cattle showed that nutrition can also alter markers of inflammation and oxidative stress \[[@dvx019-B48]\]; in rats, a protein-restricted diet in pregnancy leads to an increased susceptibility to oxidative stress in offspring \[[@dvx019-B49]\], while in humans, a high carbohydrate diet increases the oxidative stress response \[[@dvx019-B50]\]. A high-fat, high-carbohydrate meal can induce oxidative and inflammatory stress as reflected by increased reactive oxygen species (ROS) generation in both normal weight \[[@dvx019-B51]\] and in obese people \[[@dvx019-B52]\], suggesting that oxidative stress and inflammation are major mechanisms involved in metabolic disorders associated with obesity \[[@dvx019-B53]\] and can also induce epigenetic changes \[[@dvx019-B35]\]. Environmental stress can induce DNA and histone-modified changes in gene expression in organisms ranging from plants \[[@dvx019-B54]\] to humans \[[@dvx019-B55]\]. In terms of applicability to health, we know that low doses of ROS, from calorie-restricted or high-carbohydrate diets, promote health and lifespan in numerous species \[[@dvx019-B56]\]. Thus, considering the above, along with the PAR hypothesis, it is likely that such biological responses to nutrition reflect the idea that induced epigenetic changes that underpin physiological change and aid in the adaptation of an individual, and potentially its offspring, to an adverse environment \[[@dvx019-B57]\].

Thus, considering that gene-specific studies of altered nutrition have demonstrated broad and diverse genetic and epigenetic consequences, it is pertinent to apply this concept to the whole genome. Nutrition is commonly investigated as an environmental factor that is expected to influence the epigenetic landscape, and there are several examples in the literature of response to altered nutrition being inherited multigenerationally \[[@dvx019-B27], [@dvx019-B58]\] and transgenerationally (F3 and beyond, \[[@dvx019-B31]\]). As such, altered gene expression, via epigenetic marks in response to nutrition, coupled with the PAR hypothesis, could be the key to understanding the prevalence of obesity and metabolic syndrome. Here, we explore the PAR hypothesis and the ability of nutrition to affect gene expression at a whole-genome level by manipulating the diet of the fruitfly, *Drosophila melanogaster*, to investigate the extent to which gene expression is changed by differing levels of macronutrients. Previous research has shown that a high-sugar maternal diet can alter the body composition of larval *Drosophila* offspring for at least two generations \[[@dvx019-B29]\], as well as demonstrating that nutrition is able to influence traits relative to metabolic syndrome, longevity and the immune response \[[@dvx019-B30], [@dvx019-B61], [@dvx019-B62]\]. Further, evidence also exists of a multigenerational response to the maternal condition (immune challenge, maternal age, Nystrand and Dowling, 2014 \[[@dvx019-B63]\]). Considering such traits and responses are often under epigenetic control, we predict that dietary manipulation will have broad consequences for the expression of genes involved in epigenetic processes.

Methods
=======

Fly Husbandry
-------------

*Drosophila melanogaster* stocks used in this study were wild-type Canton-S flies from the Bloomington Drosophila Stock Center at Indiana University. *Drosophila* were cultured in a dedicated invertebrate laboratory using standard techniques. Briefly, flies were maintained in laboratory incubators at 25°C in a P Selecta HOTCOLD-C incubator. Larvae were reared on either a standard low-protein high-carbohydrate (LPHC, standard laboratory fly food) or a high-protein low-carbohydrate (HPLC) diet. These differential diets consisted of standard brewer's yeast (Health2000, New Zealand), sugar (New Zealand Sugar Company, Auckland, New Zealand) and cornmeal (Health 2000) in varying ratios ([Table 1](#dvx019-T1){ref-type="table"}). Agar (A7002, Sigma-Aldrich, St Louis, MO, USA), propionic acid (Thermo Fisher, New Zealand, AJA693) and Nipagin (47889, Sigma-Aldrich, 10% w/v in 100% ethanol) were added in equal amounts. Gross energy (kJ/g) of both the LPHC and HPLC food types was determined by bomb calorimetry, and total protein content (%) was calculated using the total combustion method ([Table 1](#dvx019-T1){ref-type="table"}) by the Institute of Food, Nutrition and Human Health at Massey University, Palmerston North, New Zealand. Table 1:Fly diet components and content informationComponentHigh proteinLow proteinAgar (g)99Cornmeal (g)66.766.7Sugar (g)31.2446.7Yeast (g)148.7616.7Propionic acid (ml)6.66.6Nipagen (ml)55Water (l)11Protein (%)85.3Gross energy (kJ/g)0.92.1Yeast:sugar ratio1:0.21:2.8

Nutrition Experiments
---------------------

*Drosophila* were manipulated under anaesthesia (CO~2~) and initially raised on LPHC (low-protein, high-carbohydrate, standard fly) food. To enable mating, 50 female flies were segregated within 4 h of eclosion and incubated with 10--15 male flies, on LPHC food, for 24 h. Female flies were separated and incubated on either LPHC or HPLC diet. Female flies laid eggs in their specified food and the F1 offspring from the HPLC diet were either maintained on HPLC, or mismatched onto LPHC diet ([Fig. 1](#dvx019-F1){ref-type="fig"}). The further offspring then remained on those matched or mismatched diets, relative to the F0 generation. Thus, the biological mismatch relates to flies from an HPLC (non-standard) dietary background that are mismatched onto an LPHC background.

![Fly diet experiments. LPHC, low-protein, high-carbohydrate (standard) diet; HPLC, high-protein low-carbohydrate diet; F1(M), F2(M) and F3(M), flies maintained on LPHC diet for three generations; F1(MM), F2(MM) and F3(MM), flies that were raised on HPLC in the F0 generation, and mismatched back to LPHC at eclosion in the F1 generation and were maintained for two more generations on the mismatched (LPHC) diet. Two replicates of each condition were used for transcriptomic experiments.](dvx019f1){#dvx019-F1}

At each generation, RNA was extracted from female *Drosophila* at 5 days post-eclosion using a modified kit protocol ([Supplementary File 1](#sup1){ref-type="supplementary-material"}). Following the extraction process, RNA was stored at −80 °C until needed.

Transcriptomic Experiments
--------------------------

Two F0 generation replicates from each of the LPHC and HPLC diets and two replicates from the F1, F2 and F3 generations with matched and mismatched diets were prepared, resulting in 16 total RNA samples submitted to the Otago Genomics and Bioinformatics Facility at the University of Otago (Dunedin, New Zealand) under contract to the New Zealand Genomics Limited for library construction and sequencing. The libraries were prepared using TruSeq stranded mRNA sample preparation kit according to the manufacturer's protocol (Illumina). All libraries were normalised, pooled and pair-end sequenced on 2 lanes of high-output flowcell HiSeq 2500, V3 chemistry (Illumina), generating 100 bp reads. Libraries had an average insert size of ∼208 bp.

Transcriptomic output was analysed in CLC Genomics Workbench Version 8.5.1. Reads were aligned to the *D.melanogaster* reference genome (BDGP6) as implemented in CLC Genomics Workbench, and differential gene expression (EDGE test) was calculated between samples using an absolute fold change value of \>1.5, and an false discovery rate-corrected *P*-value of \<0.001. These values were selected so that the fold change was of high enough magnitude that it could be validated in the lab by Nanostring, and the *P*-value was stringent to reduce false positives. Transcriptomic data were validated by Nanostring: samples were submitted to the Otago Genomics and Bioinformatics Facility at the University of Otago (Dunedin, New Zealand) under contract to the New Zealand Genomics Limited for nCounter Custom Gene Expression assays (Nanostring). Total RNA (100 ng) in a total volume of 5 µL was processed using the standard nCounter XT Total RNA protocol \[[@dvx019-B64]\]. Raw data were exported and QC-checked using Nanostring's nSolver data analysis tool ([www.nanostring.com](http://www.nanostring.com)). Per the Nanostring CodeSet design criteria, 25 candidate genes for validation were chosen, including two housekeeping genes incorporated (Mnf and Rpl32, [Table 2](#dvx019-T2){ref-type="table"}). Raw data were normalized to the geometric mean of both the positive controls (included in the hybridisation steps) and the nominated housekeeping genes. Normalized Nanostring data were compared with transcriptomic data, and the Pearson's correlation coefficient was calculated in R \[[@dvx019-B65]\]. Table 2:Codeset design for NanostringGeneAccessionPositionNSIDasf1NM_079439.2601--700NM_079439.2: 600Caf1-105NM_136745.31231--1330NM_136745.3: 1230DefNM_078948.28--107NM_078948.2: 7E(bx)NM_167819.24681--4780NM_167819.2: 4680E(Pc)NM_078974.22551--2650NM_078974.2: 2550E(spl)m4-BFMNM_079786.1241--340NM_079786.1: 240E(spl)m5-HLHNM_079787.2396--495NM_079787.2: 395Fbp1NM_079341.13001--3100NM_079341.1: 3000MnfNM_168444.1866--965NM_168444.1: 865HmlNM_079336.27236--7335NM_079336.2: 7235Hmt4-20NM_130497.23201--3300NM_130497.2: 3200InosNM_058057.41026--1125NM_058057.4: 1025Lip3NM_057983.3946--1045NM_057983.3: 945Lsd-1NM_170092.2836--935NM_170092.2: 835Lsp1betaNM_057276.31351--1450NM_057276.3: 1350OchoNM_080514.1416--515NM_080514.1: 415PcNM_079475.2991--1090NM_079475.2: 990PgmNM_079936.2841--940NM_079936.2: 840Rpl32NM_170461.1342--441NM_170461.1: 341Sap30NM_132934.2216--315NM_132934.2: 215Su(var)3-3NM_140937.21781--1880NM_140937.2: 1780Su(var)3-7NM_079618.23516--3615NM_079618.2: 3515Top2NM_057412.33111--3210NM_057412.3: 3110Tps1NM_134983.22056--2155NM_134983.2: 2055UbxNM_206497.11321--1420NM_206497.1: 1320[^2]

Gene Ontology Analyses
----------------------

Functional annotation clustering (FAC) was undertaken in the Database for Annotation, Visualization and Integration of Discovery (DAVID) v6.8 \[[@dvx019-B66], [@dvx019-B67]\] with the following categories: COG_ONTOLOGY, GOTERM_BP_DIRECT, GOTERM_CC_DIRECT, GOTERM_MF_DIRECT, KEGG_PATHWAY and INTERPRO. Up- and down-regulated genes from the F0 generation were submitted separately to DAVID for FAC and analysed against a background of genes that were expressed and detectable in this dataset, to identify gene oncology (GO) terms that were significantly enriched between the HPLC and LPHC F0 generation.

Statistical Analyses
--------------------

Significant differences in mean gene expression between different dietary conditions and generations were calculated via analysis of variance (ANOVA) and Tukey's *posthoc* testing, as implemented in R \[[@dvx019-B65]\].

Results
=======

RNAseq Data
-----------

Summary statistics for transcriptomic work is shown in [Supplementary File 2](#sup2){ref-type="supplementary-material"}. Briefly, each sample yielded between 3164 Mbases and 4286 Mbases (average 4001 Mbases), with an average number of reads of 32 006 648 reads (range 25 310 758--34 288 584 reads). The mean quality score was an average of 36 Q (range 35.4--35.72 Q).

Differential Gene Expression
----------------------------

Of 17 490 genes annotated in the *Drosophila* genome and contained within the CLC reference database, 12 424 were expressed and detected across generations in these transcriptomic experiments. At F0, of these 12 424 genes, 2946 were differentially expressed between HPLC and LPHC \[1074 (8.6%) down-regulated and 1872 (15.1%) up-regulated ([Supplementary File 3](#sup3){ref-type="supplementary-material"})\], with an absolute fold change of \>1.5, and an FDR-corrected *P*-value of \<0.001, as determined by EDGE test as implemented in CLC table.

Gene Ontology
-------------

DAVID uses a clustering approach to reduce redundancy; GO terms that are similar, are clustered together. Each term within the cluster is given a *P*-value, and the cluster itself is given an enrichment score (the geometric mean in --log scale of the individual GO term *P*-values). An enrichment score of 1.3 is equivalent to a non-log *P*-value of 0.05.

Functional annotation clustering of genes that are up-regulated in HPLC vs. LPHC indicated that the data set was highly enriched for genes that are involved in epigenetic processes such as chromatin binding \[enrichment score (ES) 10.64\], DNA replication (ES 4.64), chromatin regulation (ES 1.62), histone binding and phosphorylation (ES 1.60) ([Table 3](#dvx019-T3){ref-type="table"}). Conversely, clustering of genes that are down-regulated in HPLC vs. LPHC indicated that the data set was highly enriched for genes that are involved in immunity (ES 11.41), fatty acid metabolism (ES 3.49), neurotransmission (ES 3.35), cellular metabolic processes (ES 2.49) and oxidative stress pathways (ES 2.19, [Table 4](#dvx019-T4){ref-type="table"}). [Table 5](#dvx019-T5){ref-type="table"} lists the GO term classes and protein classes that are significantly up- or down-regulated in the F0 (HPLC vs. LPHC) generations, followed by those GO terms and protein classes that are up- or down-regulated in MM vs. M flies at each of the F1, F2 and F3 generations. Table 3:Functional annotation clustering (FAC) as performed in DAVIDAnnotation categoryTermEnrichment scoreGeneFlyBase gene IDFunction*P*-value of ANOVASignificance of ANOVAInterproZinc finger10.64Bre1FBgn0086694Ubiquitinates histone H2B on lysine 120 at most RNA Polymerase II transcribed genes0.0304\*pygoFBgn0043900Binds His3 methylated tail to associate with arm as part of Wnt-induced transcription0.0030\*\*e(y)3FBgn0087008PBAF complex, chromatin binding and gene silenecing0.0596.nejFBgn0261617Acetylates histone proteins and regulated gene expression0.1420NSE(bx)FBgn0000541Nucleosome remodelling, chromatin organization0.0809NSPclFBgn0003044Chromatin binding, co-localizes with the ESC/E(Z) complex0.0439\*Interpro/GOTERM_MF_DIRECTZinc finger, DNA binding4.64E(var)3-9FBgn0260243Chromatin maintenance0.0014\*\*Br140FBgn0033155Enhancer of polycomb-like0.0027\*\*MTA1-likeFBgn0027951Chromatin binding, chromosome condensation0.0665.spn-EFBgn0003483Chromatin binding, chromosome condensation0.0153\*hangFBgn0026575Response to oxidative stress0.0031\*\*pholFBgn0035997Polycomb group protein recruitment to polycomb response elements0.0006\*\*\*Chd1FBgn0250786Remodelling and assembly of chromatin0.0865.Cp190FBgn0000283Chromatin binding0.0165\*cgFBgn0000289Binds to polycomb response elements0.0047\*\*su(Hw)FBgn0003567Negative regulation of chromatin silencing0.0058\*\*Chd3FBgn0023395Chromatin assembly or disassembly, nucleosome remodelling0.0027\*\*GOTERM_BP/MF/CC_DIRECT, INTERPRODNA replication, MCM complex4.42Orc1FBgn0022772origin recognition complex, DNA replication, chromatin binding0.0013\*\*Orc4FBgn0023181Initiation of DNA replication0.0136\*Orc2FBgn0015270DNA replication, chromatin binding0.0004\*\*\*Mcm5FBgn0017577Chromatin binding, chromosome condensation0.0008\*\*\*RecQ4FBgn0040290DNA stability, DNA rewinding0.0047\*\*Mcm10FBgn0032929Heterochromatin organisation, chromatin silencing0.0008\*\*\*polybromoFBgn0039227Chromatin binding0.0104\*GOTERM_BP/MF/CC_DIRECT, INTERPROMicrotublues, kinesin4.05cidFBgn0040477Histone H3 variant, epigenetic mark for centromere identity0.0000\*\*\*GOTERM_MF_DIRECT, INTERPROHelicase3.10XNPFBgn0039338Heterochromatin organization, chromatin silencing0.0924.me31BFBgn0004419Gene silencing by miRNA0.0001\*\*\*Mi-2FBgn0262519Chromatin binding, nucleosome binding0.0261\*INTERPROStructural maintenance of chromosomes2.61SMC2FBgn0027783Chromatin binding, chromosome condensation0.0020\*\*gluFBgn0015391Chromatin binding, chromosome condensation0.0146\*SMC1FBgn0040283Chromatin binding0.0263\*SMC3FBgn0015615Chromatin binding0.0129\*GOTERM_CC/BP_DIRECTRb-E2F complex, Myb complex2.32morFBgn0002783Brahma associated proteins complex, PBAF complex0.0100\*INTERPRO, GOTERM_MF_DIRECTChromo domain1.99ChroFBgn0044324Histone binding, chromosome organization0.0098\*\*Chd1FBgn0250786Remodelling and assembly of chromatin0.0865.Mi-2FBgn0262519Chromatin binding, nucleosome binding0.0261\*msl-3FBgn0002775Methylated histone binding, chromatin binding0.1760NSChd3FBgn0023395Chromatin assembly or disassembly, nucleosome remodelling0.0027\*\*GOTERM_MF/BP_DIRECTNucleosome mobilisation, nucleosome binding1.76dre4FBgn0002183Chromatin binding, nucleosome binding0.0021\*\*E(bx)FBgn0000541Histone binding, chromatin organization, chromatin remodelling0.0809.Su(z)12FBgn0020887Polycomb repressive complex 2, histone methyltransferase activity\'0.0391\*INTERPROWD40 repeat1.67HiraFBgn0022786Chromatin binding0.0000\*\*\*Caf1-105FBgn0033526Chromatin assembly factor, histone binding0.0001\*\*\*wdsFBgn0040066Histone acetyltransferase activity, chromatin remodelling, Trx complex0.0032\*\*ebiFBgn0263933Chromatin binding0.0070\*\*GOTERM_BP/CC_DIRECTHistone phosphorylation1.6borrFBgn0032105Histone phosphorylation, chromatin binding0.0006\*\*\*ballFBgn0027889Histone threonine kinase activity, histone phosphorylation0.0009\*\*\*aurBFBgn0024227Chromatin organization0.0004\*\*\*[^3]Table 4:Functional annotation clustering (FAC) as performed in DAVIDAnnotation categoryTermEnrichment scoreGeneFlyBase gene IDFunction*P*-value of ANOVASignificance of ANOVAINTERPROImmunoglobulin-like domain/fold11.42meshFBgn0051004Ig fold0.000611\*\*\*PpnFBgn0003137Ig domain, extracellular matrix structural constituent0.0101\*INTERPRO/GO_TERM_BP_DIRECT/GOTERM_MF_DIRECTProteolysis, peptidase6.16Jon65AiFBgn0035667Serine-type endopeptidase, proteolysis0.00293\*\*MP1FBgn0027930Serine-type endopeptidase, proteolysis0.00187\*\*thetaTryFBgn0011555Digestive enzyme with serine-type peptidase activity1.68E-08\*\*\*zetaTryFBgn0011556Digestive enzyme with serine-type peptidase activity0.000488\*\*\*DecayFBgn0028381Cysteine-type endopeptidase activity, caspase0.00188\*\*DammFBgn0033659Cysteine-type endopeptidase activity, caspase6.79E-06\*\*\*alphaTryFBgn0003863Serine-type endopeptidase, proteolysis5.69E-05\*\*\*Ser7FBgn0019929Serine-type endopeptidase, proteolysis1.51E-12\*\*\*Ser6FBgn0011834Serine-type endopeptidase, proteolysis5.17E-03\*\*SwimFBgn0034709Polysaccharide binding, cysteine-type peptidase activity, proteolysis1.35E-02\*Jon74EFBgn0023197Serine-type endopeptidase, proteolysis1.58E-03\*\*pshFBgn0030926Peptidase and serine-type endopeptidase activity, defense response4.41E-08\*\*\*Jon65AivFBgn0250815Serine-type endopeptidase, proteolysis1.74E-04\*\*\*Jon65AiiiFBgn0035665Serine-type endopeptidase, proteolysis6.77E-05\*\*\*Ance-4FBgn0033366Peptidase6.97E-04\*\*\*AnceFBgn0012037peptidyl-dipeptidase activity6.97E-04\*\*\*Jon25BiiFBgn0031654Serine-type endopeptidase, proteolysis8.62E-04\*\*\*GOERM_BP_DIRECT/INTERPRO/GOTERM_MF_DIRECTG-protein-coupled receptor signalling, rhodopsin-like6.02Rh3FBgn0003249G-protein coupled photoreceptor activity3.73E-03\*\*AkhRFBgn0025595Ccarbohydrate, lipid and tryglyceride homeostasis1.88E-09\*\*\*Rh2FBgn0003248G-protein coupled photoreceptor activity4.65E-02\*GalphasFBgn0001123Signal transduction, chemical synaptic transmission1.07E-11\*\*\*ninaEFBgn0002940G-protein coupled photoreceptor activity, rhodopsin-like2.80E-05\*\*\*Ggamma1FBgn0004921G-protein, gamma subunit, signal transducer activity4.16E-05\*\*\*Gbeta76CFBgn0004623G-protein coupled photoreceptor activity2.71E-02\*Rh4FBgn0003250G-protein coupled photoreceptor activity1.83E-03\*\*GOTERM_MF_DIRECT/GOTERM_BP_DIRECTFatty acid elongation3.49eloFFBgn0037762Fatty acid elongase4.60E-05\*\*\*GOTERM_MF_DIRECTNeuropeptide hormone activity/binding3.35Nplp2FBgn0040813Neuropeptide signaling, humoral immune response1.39E-02\*Nplp3FBgn0042201Neuropeptide hormone activity, neuropeptide signaling3.45E-01NSNeb-cGPFBgn0083167Hormone activity, regulation of growth3.72E-02\*GOTERM_MF/CC/BP_DIRECTCalcium-dependent phospholipid binding2.72AnxB9FBgn0000083calcium ion binding, calcium-dependent phospholipid binding7.69E-03\*\*GPTERM_MP_DIRECT, INTERPRO, COG_ONTOLOGYCalcium ion binding, signal transduction, EF-hand domain2.5CalsFBgn0039928Calcium ion binding, chemical synaptic transmission2.29E-02\*GelFBgn0010225Actin binding, calcium ion binding1.52E-03\*\*Scp2FBgn0020907Calcium ion binding3.43E-02\*Scp1FBgn0020908Calcium ion binding8.74E-02.Mlc2FBgn0002773Calcium ion binding3.33E-04\*\*\*Zasp52FBgn0265991Muscle development3.91E-08\*\*\*LpR1FBgn0066101Uptake of neutral lipids from circulation, calcium ion binding4.93E-01NSMlc1FBgn0002772Calcium ion binding, myosin3.91E-04\*\*\*upFBgn0004169Calcium ion binding, calcium ion homeostatis, muscle morphogenesis3.26E-04\*\*\*TpnC73FFBgn0010424Calcium ion binding3.01E-10\*\*\*Gpo-1FBgn0022160Glycerol-3-phosphate dehydrogenase activity, calcium ion binding0.000209\*\*\*INTERPRO, GOTERM_MF/BP/CC_DIRECTFatty acyl-CoA reductase, peroxisome2.47watFBgn0039620Long-chain-fatty-acyl-CoA reductase activity, oxidation-reduction process1.21E-06\*\*\*SpatFBgn0014031Amino transferase activity, glyoxylate catabolic process, proxisome2.02E-02\*CatFBgn0000261Catalase, antioxidant activity and ROS metabolic process1.15E-02\*UroFBgn0003961Urate oxidase activity, oxidation-reduction process, peroxisome1.96E-02\*Acox57D-dFBgn0034629acyl-CoA dehydrogenase activity, fatty acid beta-oxidation, peroxisome4.63E-05\*\*\*GOTERM_MF/BP/CC_DIRECT, INTERPROOxidation−reduction, haeme binding, iron ion binding, Cytochrome P4502.2MenFBgn0002719Malic oxidoreductase, determination of adult lifespan5.16E-04\*\*\*Cyp6a23FBgn0033978Cytochrome P450, heme and iron ion binding, oxidation-reduction process4.93E-01NSCyp4p1FBgn0015037Cytochrome P450, heme and iron ion binding, oxidation-reduction process7.98E-02.CprFBgn0015623NADPH-hemoprotein reductase activity, oxidation-reduction process2.27E-04\*\*\*Cyt-b5-rFBgn0000406Heme binding, oxidoreductase activity, lipid metabolic process2.69E-04\*\*\*antdhFBgn0026268Oxidoreductase activity, oxidation-reduction process4.85E-02\*AOX1FBgn0267408Aldehyde oxidase, pyridoxal oxidase activity5.82E-03\*\*Cyt-b5FBgn0264294Cytocrome b5-like heme-binding site6.47E-04\*\*\*Cyp313a1FBgn0038236Cytochrome P450, heme and iron ion binding, oxidation-reduction process1.45E-02\*mt: CoIFBgn0013674Mitochondrial Cytochrome C oxidase, heme and iron binding7.39E-02.AldhFBgn0012036Aldehyde dehydrogenase, oxidation-reduction9.39E-03\*\*Cyp4e3FBgn0015035Cytochrome P450, heme and iron ion binding, oxidation-reduction process1.27E-05\*\*\*hgoFBgn0040211Homogentisate 1, 2-dioxygenase activity, oxidation-reduction process4.08E-03\*\*PdhFBgn0011693Retinol and alcohol dehydrogenase activity, oxidation-reduction process4.75E-03\*\*Desat1FBgn0086687Fatty acid desaturase, oxidation-reduction process2.55E-05\*\*\*PlodFBgn0036147Iron ion binding, oxidoreductase activity, oxidation-reduction process6.75E-04\*\*\*Fad2FBgn0029172Fatty acid desaturase, oxidation-reduction process, lipid metabolic process1.15E-03\*\*GpdhFBgn0001128Carbohydrate metabolic process, oxidation-reduction process6.13E-04\*\*\*GOTERM_BP/CC/MF_DIRECTCalcium ion channel, transmembrane transport2.13trplFBgn0005614Calcium channel activity, calcium ion transport2.13E-02\*trpFBgn0003861Plasma membrane cation channel, calcium channel3.06E-09\*\*\*GOTERM_BP/CC/MF_DIRECTVoltage-gated potassium channel activity2.03Irk3FBgn0032706Potassium channel activity, potassium ion transport3.88E-02\*KEGG_PATHWAY, INTERPRO, GOTERM_BP/CC/MF_DIRECTFatty acid metabolism/biosynthetic process1.93ACCFBgn0033246Acetyl-CoA carboxylase activity, fatty acid biosybthetic process3.44E-03\*\*Cyt-b5-rFBgn0000406Cytochrome b5-like heme binding, lipid metabolic process6.47E-04\*\*\*Desat1FBgn0086687Fatty acid desaturase, oxidation-reduction process2.55E-05\*\*\*Fad2FBgn0029172Fatty acid desaturase, oxidation-reduction process, lipid metabolic process1.15E-03\*\*AcslFBgn0263120Long-chain fatty acid-CoA ligase activity1.03E-04\*\*\*INTERPRO, GOTERM_MF_DIRECTCarbohydrate binding1.91Clect27FBgn0031629Carbohydrate binding4.40E-11\*\*\*lectin-37DbFBgn0053533Galactose binding2.68E-04\*\*\*INTERPRO, GOTERM_MF_DIRECTPotassium ion transport, oxalate transmembrane transporter activity1.65Irk3FBgn0032706Potassium channel activity, potassium ion transport3.88E-02\*Irk2FBgn0039081Potassium channel activity, potassium ion transport1.96E-08\*\*\*Dic1FBgn0027610Inorganic phosphate transmembrane transporter activity3.33E-05\*\*\*GOTERM_MF/BP/CC_DIRECT, INTERPRONeurotransmitter-gated ion-channel ligand binding1.45CalsFBgn0039928Calcium ion binding2.29E-02\*GOTERM_MF/BP/CC_DIRECT, INTERPRO, COG_ONTOLOGYReceptor activity, carboxylesterase, lipid metabolism1.35alpha-Est7FBgn0015575Carboxylic ester hydrolase activity, lipid storage, determination of lifespan2.49E-04\*\*\*ACCFBgn0033246Acetyl-CoA carboxylase activity, fatty acid biosybthetic process3.44E-03\*\*Gs2FBgn0001145Glutamate catabolic process, neurotransmitter receptor metabolic process1.46E-03\*\*Est-6FBgn0000592Carboxylic ester hydrolase activity2.93E-02\*AcCoASFBgn0012034Acetyl-CoA ligase activity3.35E-04\*\*\*GOTERM_MF/BP/CC_DIRECT, INTERPRONeurotransmitter transporter1.32NAAT1FBgn0029762Neurotransmitter transporter activity2.06E-08\*\*\*Eaat1FBgn0026439Glutamate: sodium symporter activity, determination of adult lifespan2.06E-02\*[^4]Table 5:A functional annotation comparison of up and downregulated genes at each generationF0F1F2F3GO categoryGO term*n* = 1074*n* = 1867*n* = 541*n* = 1684*n* = 17*n* = 22*n* = 1893*n* = 2720↑ expression in HPLC↓ expressison in HPLC↓ expression in MM↑ expression in MM↓ expression in MM↑ expression in MM↓ expression in MM↑ expression in MM**Biological process\# genes**% of total**\# genes% of total\# genes% of total\# genes% of total\# genes% of total\# genes% of total\# genes% of total\# genes**% of total Biological adhesionGO: 002261030.30341.9010.20291.9017.1070.40351.50 Biological regulationGO: 0065007807.601277.00255.101097.2014.501437.501757.40 Cellular component organization or biogenesisGO: 0071840938.90633.50367.30513.4014.501769.20984.10 Cellular processGO: 000998737035.3047526.3016433.5038325.50214.30418.2069636.3060225.50 Developmental processGO: 0032502373.501045.80112.20895.9029.10703.601476.20 Immune system processGO: 0002376101.00261.4051.00251.70160.80331.40 LocalizationGO: 0051179787.401397.70255.101308.60214.3029.101517.901948.20 LocomotionGO: 004001140.4010.1020.4010.1060.3010.00 Metabolic processGO: 000815238336.5039321.8017936.5032821.80535.70522.7070836.9050821.50 Multicellular organismal processGO: 0032501181.701277.0061.20906.0029.10281.501626.90 ReproductionGO: 0000003161.50301.7091.80241.6014.50281.50361.50 Response to stimulusGO: 0050896757.201246.90336.701067.0014.501407.301667.00 Rhythmic processGO: 0048511140.8010.20130.9014.5010.10140.60**Protein class\# genes% of total\# genes% of total\# genes% of total\# genes% of total\# genes% of total\# genes% of total\# genes% of total\# genes% of total** Calcium-binding proteinPC0006040.40271.5010.20140.90170.90351.50 Cell adhesion moleculePC0006920.20241.30161.1050.30301.30 Cell junction proteinPC0007030.30%80.40100.7050.30140.60 ChaperonePC0007280.80%30.2020.40%30.20140.7070.30 Cytoskeletal proteinPC00085413.90%442.40173.50%382.50593.10592.50 Defense/immunity proteinPC0009020.20%80.4010.20%70.5070.40100.40 Enzyme modulatorPC00095424.00%593.30142.90%513.4014.50%1015.30723.00 Extracellular matrix proteinPC00102221.20161.1030.20261.10 HydrolasePC00121737.00%1448.00306.10%1318.70428.60%29.10%1427.401817.70 IsomerasePC0013550.50%50.3080.50130.7070.30 LigasePC00142242.30%201.1081.60%151.0017.10%14.50%482.50251.10 LyasePC0014440.40%281.60201.30150.80251.10 Membrane traffic proteinPC0015060.60%160.90151.00140.70210.90 Nucleic acid bindingPC0017116415.60%724.008818.00%604.0029615.401345.70 OxidoreductasePC00176212.00%945.20122.40%674.50432.20964.10 ReceptorPC00197121.10%814.5051.00%644.3017.10%281.501074.50 Signalling moleculePC00207121.10%563.1030.60%493.3014.50%241.30723.00 Storage proteinPC0021030.30%70.4020.40%40.3050.3080.30 Structural proteinPC0021120.2020.1010.2030.2070.4030.10 Transcription factorPC00218817.70683.80336.70%593.901306.801175.00 Transfer/carrier proteinPC00219131.20%362.0010.20%312.10281.50512.20 TransferasePC00220625.90%563.10255.10%493.3014.50%1316.80662.80 Transmembrane receptor regulatory/adaptor proteinPC0022610.10%60.3081.60%40.3030.2050.20 TransporterPC00227282.70%1407.801087.20472.501687.10 Viral proteinPC0023710.10**Molecular function\# genes% of total\# genes% of total\# genes% of total\# genes% of total\# genes% of total\# genes% of total\# genes% of total\# genes% of total** Antioxidant activityGO: 001620920.2090.5030.6070.5050.30120.50 BindingGO: 000548825824.6024013.3011723.9020113.4017.10%14.50%45523.7034914.80 Catalytic activityGO: 000382426525.3041222.8012325.1035223.40%535.70%418.20%52427.3048320.40 Channel regulator activityGO: 001624710.00 Receptor activityGO: 000487280.80543.0051.00473.1017.10180.90743.10 Signal transducer activityGO: 000487130.30120.7010.2080.5070.40190.80 Structural molecule activityGO: 0005198222.10643.5061.20442.90452.30873.70 Translation regulator activityGO: 004518220.2010.1010.201157.6090.5030.10 Transporter activityGO: 0005215343.201498.30132.7017.1014.50583.001777.50[^5]

Validation
----------

Based on the genes that were up-regulated in this study, we selected a panel for 20 genes for transcriptomic data validation. All transcriptomic samples were validated by Nanostring, per-sample *r* value of 0.81--0.95 and whole data set correlation *r* of 0.86 ([Supplementary File 4](#sup4){ref-type="supplementary-material"}).

Multigenerational Gene Expression of Genes of Interest
------------------------------------------------------

Alteration of diet appears to lead to a characteristic suite of gene expression changes. To determine whether the suite of up-regulated genes observed in HPLC is maintained across mismatched generations when the HPLC diet is removed, we analysed the expression levels of particular groups of genes classed as having roles in epigenetic processes in F1, F2 and F3 matched (M) and mismatched (MM) flies. We observed a specific pattern of expression for every gene; the intermediate-level maintenance of the up-regulation of the genes in the F1 and F2 generation, followed by a reversion to F0 (matched) gene expression levels by the F3 generation. [Fig. 2](#dvx019-F2){ref-type="fig"} displays a selection of indicative graphs which display this effect, with ANOVA significance data listed in [Table 3](#dvx019-T3){ref-type="table"} (described in [Supplementary File 5](#sup5){ref-type="supplementary-material"}) and significant pairwise comparisons as determined by Tukey's *posthoc* testing ([Supplementary File 6](#sup6){ref-type="supplementary-material"}) indicated by solid and dashed lines. There is no significant difference between the expression of epigenetic genes when comparing the F0 LPHC diet and the F3MM flies, despite an intermediate and significant difference between F1 and F2 flies mismatched onto LPHC diets. For genes that were significantly down-regulated in F0 HPLC flies, we observe the same pattern of gene expression in the opposite direction; genes that are down-regulated in response to diet remain at a low level in the F1 and F2 mismatched cohorts (F1MM and F2MM) but by F3, their gene expression has regained the same level as the LPHC (F0) generation ([Fig. 3](#dvx019-F3){ref-type="fig"} and [Supplementary Files 5 and 7](#sup5){ref-type="supplementary-material"}). This effect is genomewide, and applies to every gene tested from the lists generated by DAVID.

![Indicative graphs of gene expression of genes up-regulated in the F0 generation, with significances as determined by ANOVA, between F0 and F3 generations on matched and mismatched diets. Pairwise comparisons by Tukey's *post hoc* testing indicated by solid and dashed lines, as described in the key. *Y* axis denotes mean expression level from transcriptomic experiments, and *X* axis denotes the dietary condition as per [Figure. 1](#dvx019-F2){ref-type="fig"}. Note differing *Y* axis scales. Gene names are stated as per their FlyBase gene symbol IDs.](dvx019f2){#dvx019-F2}

![Indicative graphs of gene expression of genes down-regulated in the F0 generation, with significances as determined by ANOVA, between F0 and F3 generations on matched and mismatched diets. Pairwise comparisons by Tukey's *post hoc* testing indicated by solid and dashed lines, as described in the key. *Y* axis denotes mean expression level from transcriptomic experiments, and *X* axis denotes the dietary condition as per [Figure. 1](#dvx019-F1){ref-type="fig"}. Note differing *Y* axis scales. Gene names are stated as per their FlyBase gene symbol IDs.](dvx019f3){#dvx019-F3}

Discussion
==========

The primary goal of this study was to investigate the effect of nutrition on the expression of genes involved in epigenetic processes. We have demonstrated that an HPLC diet results in genomewide up-regulation of epigenetic genes in the F0 generation compared to that observed in a standard *Drosophila* LPHC diet; this effect was so strong that the overwhelming majority of genes that were up-regulated in response to diet had GO terms categorized as being involved in epigenetic processes, with very few other classes of genes categorized as significantly up-regulated. Classes of genes that were down-regulated in response to the HPLC diet vs. LPHC were broader in scope; these included genes that have GO terms with roles in the immune response, cell signalling, oxidative stress, carbohydrate and fatty acid metabolism and neurotransmission. Thus, this study shows that altering an LPHC diet to an HPLC results in genomewide up-regulation of genes classified as having roles in epigenetic processes, with a co-ordinated down-regulation of genes classified as having broad physiological functions. The co-ordinated nature of the gene expression data we observed imply, firstly, that genes with GO terms categorized as having roles in the processes of neurotransmission, oxidative stress, metabolism and immunity appear to be under epigenetic control, and, secondly, that this epigenetic control, and altered biological response, is influenced by nutrition.

In response to the genomic and epigenomic changes observed in the F0 generation, we further questioned whether dietary alteration resulted in developmental programming of the biological response to diet; specifically, whether the changes induced by the HPLC diet in the F0 generation persisted beyond F0, upon removal of the HPLC diet. The genomic changes induced in the F0 generation persisted at intermediate levels in mismatched F1 and F2 generations in the absence of the HPLC diet. By the F3 generation, gene expression in the mismatched flies had reverted back to the level observed in the F0 matched generation. We hypothesize, firstly, that this multigenerational inheritance of gene expression, followed by a reversion to matched F0 levels by the time the F3 generation is reached, indicates moderate epigenetic programming in the form of a predictive adaptive response (PAR); the gene expression changes induced by the dietary environment experienced by the F0 female flies may be maintained by her offspring. This intermediate maintenance may be considered either as an adaptive response to an environment that the F1-F3MM offspring are ultimately not experiencing or maintenance could be considered a form of bet-hedging, to mean that the offspring are primed to equally respond if their environment changes. Given that these data display a reversion to the unchallenged nutritional state after three generations, we further hypothesize that the 'correction' of the induced genomic changes by F3 implies that dietary reversion to match the F0 generation may be able to correct an altered genomic landscape, effectively reversing an altered nutrition-induced phenotype.

The environment is able to interact with genes through epigenetic mechanisms \[[@dvx019-B9]\] particularly during development \[[@dvx019-B2]\]. Crucially, this could also lead to the alteration of the epigenome of the germ cells \[[@dvx019-B6]\]. Any permanent alteration to the germ cell epigenome \[[@dvx019-B68]\] may then be transmitted through the germ line, with adverse phenotypic consequences for offspring \[[@dvx019-B1], [@dvx019-B69]\]. For example: adult-onset diseases can be induced through embryonic exposure to environmental toxins, primarily endocrine disruptors \[[@dvx019-B5], [@dvx019-B70]\]; toxic stress can modify *Drosophila* development by the suppression of Polycomb group genes, with epigenetic inheritance of developmental alterations by unchallenged offspring \[[@dvx019-B73]\] and; mutations in chaperone proteins such as Hsp90 can induce a heritably altered chromatin state in *Drosophila*, suggesting a transgenerational epigenetic phenotype \[[@dvx019-B74]\]. Thus, if epigenetic modifications do become permanent, these modifications can be inherited by future generations and affect disease susceptibility \[[@dvx019-B58], [@dvx019-B75]\].

A large number of studies report transgenerational inheritance in a range of eukaryotes (reviewed in \[[@dvx019-B76]\]). Many of these studies, particularly in mammals, report inheritance of the acquired trait over two or three generations. Concordant with the work by Jirtle and Skinner \[[@dvx019-B58]\], we agree that these effects should not be defined as truly transgenerational, because, mechanistically, exposure of an F0 gestating female to an environmental stimulus (nutrition, toxicants or stress) also exposes the F1 embryo ([Fig. 1](#dvx019-F1){ref-type="fig"}, \[[@dvx019-B77]\]). Furthermore, for species that develop *in utero*, parental exposure also exposes the germ cells that will form the F2 generation. Thus, traits present in the F2 generation should be considered as multigenerational, rather than transgenerational, as they could have been induced by direct environmental exposure through the foetus and the germ line. This concept is equally applicable to *Drosophila* because, while they do not gestate, they do harbour ovarioles in their ovaries which contain developing follicles or egg chambers \[[@dvx019-B78]\], thus their F1 eggs are exposed to the maternal environment. Further, F1 larvae, which in these experiments were raised on an HPLC diet before being mismatched back to LPHC, contain ovaries and germ cells for the F2 generation. Thus, to reflect this direct exposure, some studies searching for evidence of true transgenerational inheritance are declining to assay the F1 generation entirely \[[@dvx019-B79]\] due to the fact that transmission to the F1 generation can be indicative of both parental effects and programming \[[@dvx019-B80]\]. Thus, here we describe our findings from the F1 and F2 generations as multigenerational inheritance, because the gene expression changes induced by the environment in the parental generation revert to F0 levels after the F2 generation.

The current NCD epidemic is aetiologically very complex, but it is thought to be mediated, in part, by developmental aberrations arising from the inheritance of altered epigenetic marks \[[@dvx019-B2], [@dvx019-B5]\]. Many metabolic phenotypes and gene expression differences are linked to differential epigenetic marks that are nutritionally induced. For example, a protein-restricted diet during pregnancy causes hypomethylation of the hepatic PPARα and glucocorticoid receptor genes in rats and promotes the same hypomethylation in the F1 and F2 offspring of F0 rats fed a protein-restricted diet during pregnancy, despite the nutritional challenge being only in the F0 generation \[[@dvx019-B27]\]. Others have reported evidence of embryonic environmental exposure influencing the phenotype of the F1 generation in species as diverse as humans, rats, chordate fish, Daphnia and isopods \[[@dvx019-B59], [@dvx019-B60], [@dvx019-B81]\] as well as, specifically, maternal nutrition exerting effects on the F1 phenotype \[[@dvx019-B59], [@dvx019-B60]\]. Such research strongly implies that epigenetic effects could be the key to understanding the current epidemic of overweight and obese, and associated metabolic syndromes, particularly if nutrition in the F0 generation can induce a PAR to nutrition, as we hypothesize is occurring here. Interestingly, comprehensive studies using animal models that investigated the effect of both protein restricted and energy-rich diets during pregnancy on the phenotype of the offspring showed that offspring born to dams fed these different diets exhibited persistent metabolic changes, similar to those observed in human metabolic disease such as obesity, insulin resistance and hypertension \[[@dvx019-B15]\], indicating an element of developmental programming and a possible PAR. These findings imply that both famine (protein restriction) and energy-rich diets, when mismatched back to adequate nutrition, are similarly detrimental to the metabolic health of offspring and that it is possibly the mismatch itself between inadequate nutrition and proper nutrition which is leading to metabolic disease phenotypes. This highlights the fact that epigenetic mechanisms play a highly complex role in human obesity and metabolic pathways \[[@dvx019-B15], [@dvx019-B85]\].

In addition to the striking expression level changes observed in genes that have GO terms classified as having roles in epigenetic processes, one major source of change that we observed in these data are genes involved in oxidative stress. Malnutrition or excess of particular nutrients can cause oxidative damage \[[@dvx019-B88]\]. For example, hyperglycaemia, which is an excess of sugar in the blood and one of the hallmarks of diabetes, is linked to a diet that is rich in carbohydrates and fat \[[@dvx019-B89], [@dvx019-B90]\]. continuedAn accumulation of sugar can lead to tissue damage, and this can be maintained because of metabolic memory \[[@dvx019-B35]\], which itself may induce epigenetic changes and altered gene expression \[[@dvx019-B35], [@dvx019-B91], [@dvx019-B92]\]. Given that the increased carbohydrate intake can induce oxidative stress as reflected by increased ROS generation \[[@dvx019-B51], [@dvx019-B52]\], our results are consistent with the observation that high-carbohydrate diets are implicated in increased oxidative and metabolic stress \[e.g. \[[@dvx019-B49]\] and that the genome may be responding adaptively to dietary stressors\]. We know that oxidative stress responses are often under epigenetic control \[[@dvx019-B55]\] and also, that maternal nutritional deficiency in pregnancy can lead to altered methylation and increased oxidative DNA damage in the brains of adult offspring \[[@dvx019-B93]\], which, as well as being directly influenced by nutrition, may predispose to neurological disorders in later life.

Consistent with, and leading on from this observation, these data display a decrease in the expression of genes involved in neurotransmission and neurodevelopment when exposed to an HPLC diet. There is strong evidence linking oxidative stress to neurodegeneration and neurodegenerative disease, such as Alzheimer's disease \[[@dvx019-B94]\]. In addition, it is also clear that an increase in the production of ROS, induced by environmental factors, can increase the risk of a multitude of neurodegenerative diseases \[[@dvx019-B95]\]. Thus, it stands to reason that, in these data, nutrition may be impacting on the production of ROS and the expression of genes involved in ROS pathways and those involved in neurotransmission and neurodegeneration.

In addition to the DOHaD hypothesis, there are also free radical early-life theories, which link environmental agents (e.g. diet and heavy metals) with perturbations of gene regulation and expression (e.g. in the *APP* gene) and the onset of, for example Alzheimer's disease \[[@dvx019-B96]\]. Free radical early-life theories also link the necessity for oxygen in histone demethylase action to epigenetic processes in development \[[@dvx019-B97]\]. These theories are supported by the observation that nutrition during pregnancy can induce epigenetic changes that result in altered nervous system development \[[@dvx019-B98]\] and also offspring cerebral function \[[@dvx019-B99]\]. Further, nutrient availability during the pre and postnatal periods can lead to long-lasting changes in neuron development \[[@dvx019-B100]\] as well as influence the development of psychopathological behaviour \[[@dvx019-B101]\]. This is because nutritional deficit may lead to altered brain development \[[@dvx019-B102]\], possibly via epigenetic factors that can lead to changes in brain structure and function \[[@dvx019-B103]\]. Micronutrient availability can heavily influence neurotransmission, due to the fact that the function of the brain is inherently related to its metabolism of nutrients \[[@dvx019-B103]\] in the form of vitamins and minerals that function as co-enzymes in neurotransmission and neurotransmitter metabolism. Given that the gene expression data presented here display significant changes in gene expression in pathways relevant to neurotransmission, these data are supportive of these linkages.

Thus, through our data, we hypothesize that the genomewide changes we observe in genes involved in epigenetic pathways could be responsible for the gene expression changes in other, broad, biological process seen in response to diet. The intermediate maintenance of these gene expression changes, even when the HPLC diet is removed, suggests a PAR to diet; the biology of the mismatched flies is programmed to respond to a particular diet, and is responding adaptively, with altered gene expression in the absence of HPLC, albeit at a slightly lower level. The complete reversion of this in the F3 generation suggests an element of phenotypic rescue, implying that altered nutrition did not affect the germ line and that the gene expression changes are not fixed transgenerationally and thus may have the capacity to be corrected over time.

To date, while the effects of dietary manipulation on fecundity and lifespan in *Drosophila* have been reported \[[@dvx019-B30], [@dvx019-B104]\], none of the studies have assayed the whole-genome gene expression in response to diet. This study contributes to our understanding of the myriad ways in which nutrition can influence gene expression, phenotypes and future health outcomes, with relevance to the DOHaD hypothesis and the current NCD epidemic. While our study demonstrates multigenerational inheritance of gene expression values, rather than transgenerational, it is worth noting that the phenotypic effects of gene expression changes, rather than the gene expression itself, can persist and show multigenerational, and potentially transgenerational, inheritance. For example, a low-protein diet given to *Drosophila* can increase H3K27me3 through up-regulation of the Enhancer of zeste (E(z)) protein, a protein that is a catalytic component of the Polycomb Repressive Complex 2 methyltransferase. Interestingly, while the up-regulation of the (E)z protein was not detected in the F2 generation, the associated increase in methylation H3K27me3 (a specific chemical modification -- trimethylation − of histone H3 at the lysine 27 residue) was in fact detected in the F2 generation \[[@dvx019-B79]\] and the co-ordinated effect on longevity was also present through to the F2 generation. This suggests that while the gene expression and protein level is not inherited *per se*, the effects and/or functions of those genes possibly could be. It is possible that a phenomenon such as this may be present in these data; a permissive state may be achieved whereby we might not detect gene expression changes inherited to F3 and beyond, but we may see associated genomic conformational or phenotypic changes in F3 and beyond. Further functional studies based on dietary manipulation are required to confirm this. In particular, it will be pertinent to prove causality between an epigenetic alteration and a change in regulation of genes involved in the traits we observe. To do so, we suggest a combination of phenotypic measures such as assessing lifespan, oxidative stress resistance, and immunity, as well as exploiting mutant *Drosophila* strains for genes of interest, to assess the effect of epigenetic alterations on downstream gene expression and associated phenotypes. Further functional studies are especially pertinent due to the wealth of evidence demonstrating that high-protein diets in *Drosophila* can alter *Drosophila* development and fitness, particularly ovary development and reproductive output \[[@dvx019-B107]\], heat stress tolerance \[[@dvx019-B110], [@dvx019-B111]\], body composition \[[@dvx019-B109]\] and egg-to-adult viability \[[@dvx019-B111]\]. The different caloric content between the HPLC and LPHC diets cannot be discounted as a confounding factor; however, the wealth of evidence pertaining to the epigenetic effects of high-protein diets that support these data implies that the gene expression changes detected in these data are driven by the protein/carbohydrate content of the food, rather than a caloric difference.

Thus, here we have identified characteristic suites of genes that are responsive to altered nutrition and the maintenance of altered gene expression upon removal of the nutritional challenge in multiple generations. This has broad implications for our understanding of DOHaD, the PAR hypothesis and the NCD epidemic and will be vital in directing future functional research in this area.
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[^1]: Present address: School of Biological Sciences, University of Canterbury, Christchurch, New Zealand

[^2]: Gene, gene symbol based on FlyBase nomenclature; NSID, Nanostring internal identifier; Position, region in the target mRNA being probed.

[^3]: Genes that were significantly up-regulated in these data in HPLC compared to LPHC were compared to a background list of genes that were expressed and detected in these data. Analyses of variance were carried out on expression between all samples in this study (F0-F3 matched and mismatched) with *P*-values and statistical significances listed.

[^4]: Genes that were significantly down-regulated in these data in HPLC compared to LPHC were compared to a background list of genes that were expressed and detected in these data. Analyses of variance were carried out on expression between all samples in this study (F0−F3 matched and mismatched) with *P*-values and statistical significances listed.

[^5]: Up- and down-regulated genes at each generation were submitted to PANTHER for an analysis of their annotated function. Genes were put into gene ontology (GO) classes, and the number of genes from each of the up- and down-regulated gene list in each class is reported. F0 compares the number of genes in each GO class that are up-regulated or down-regulated in HPLC vs. LPHC. For each subsequent generation (F1−F3), the number of genes in each class is reported as those that are up- or down-regulated in mismatched (MM) flies vs. matched (M) flies, at each generation. The percentages reported are the percentage of gene hits against the total number of genes identified in each list submitted for gene functional classification.
